Skip to main content
. 2022 Oct 21;12(5):5846–5858. doi: 10.1002/cam4.5372

FIGURE 6.

FIGURE 6

Integration of TMB and the ratio of CD8 T lymphocytes to M2 macrophages could further predict the efficacy in TNBC. (A) Correlation of TMB of targeted‐panel sequencing and CD8/CD163. (B) Barplots of pCR rate and MP5 grade rate between TMB & CD8/CD163‐H group and TMB & CD8/CD163‐L group. (C) and (D) Kaplan–Meier curves of OS and DFS comparing TMB & CD8 T cells/M2 Macrophages‐H with TMB & CD8 T cells/M2 Macrophages‐L from TNBC patients in TCGA.